Chung-Kung Lai

Title: Innovations of Chung-Kung Lai in Drug Delivery Systems

Introduction

Chung-Kung Lai is a notable inventor based in Taipei, Taiwan. He has made significant contributions to the field of drug delivery systems, particularly in targeting estrogen receptor over-expressed cells. With a total of 2 patents, his work is paving the way for advancements in targeted therapies.

Latest Patents

One of his latest patents involves a drug delivery system that targets estrogen receptor over-expressed cells. This invention discloses a vector designed for the targeted delivery of drugs into these specific cells. The vector consists of a plurality of nanoparticles, which include targeted moieties conjugated to the outer surface. These moieties are capable of binding with the estrogen receptors of target cells. Additionally, bioactive agents are either encapsulated in the nanoparticles or form complexes with them. This innovative approach also allows for the targeted moiety to be conjugated to parent drugs for prodrug design.

Career Highlights

Chung-Kung Lai is affiliated with the Industrial Technology Research Institute, where he continues to develop and refine his inventions. His work is characterized by a strong focus on enhancing the efficacy of drug delivery systems, which is crucial for improving patient outcomes in medical treatments.

Collaborations

He has collaborated with notable colleagues such as Shyh-Dar Li and Ae-June Wang, contributing to a dynamic research environment that fosters innovation.

Conclusion

Chung-Kung Lai's contributions to drug delivery systems exemplify the potential of targeted therapies in modern medicine. His innovative approaches are set to make a lasting impact on the field.